相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Atezolizumab and Nab-Paclitaxel in Advanced Triple-Negative Breast Cancer
P. Schmid et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Pembrolizumab (pembro) plus chemotherapy (chemo) as neoadjuvant treatment for triple negative breast cancer (TNBC): Preliminary results from KEYNOTE-173
Peter Schmid et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
Dramatic response of metaplastic breast cancer to chemo-immunotherapy
Sylvia Adams
NPJ BREAST CANCER (2017)
Safety and clinical activity of atezolizumab (anti-PDL1) in combination with nab-paclitaxel in patients with metastatic triple-negative breast cancer
S. Adams et al.
CANCER RESEARCH (2016)
Programmed death ligand 1 expression in triple-negative breast cancer is associated with tumour-infiltrating lymphocytes and improved outcome
Rhiannon K. Beckers et al.
HISTOPATHOLOGY (2016)
Pembrolizumab in Patients With Advanced Triple-Negative Breast Cancer: Phase Ib KEYNOTE-012 Study
Rita Nanda et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
Safety and efficacy of durvalumab (MEDI4736) a PD-L1 antibody, in urothelial bladder cancer.
Christophe Massard et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
Genomic Profiling of Advanced-Stage, Metaplastic Breast Carcinoma by Next-Generation Sequencing Reveals Frequent, Targetable Genomic Abnormalities and Potential New Treatment Options
Jeffrey S. Ross et al.
ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE (2015)
The evaluation of tumor-infiltrating lymphocytes (TILs) in breast cancer: recommendations by an International TILs Working Group 2014
R. Salgado et al.
ANNALS OF ONCOLOGY (2015)
Survival Outcomes of Metaplastic Breast Cancer Patients: Results from a US Population-based Analysis
Rebecca A. Nelson et al.
ANNALS OF SURGICAL ONCOLOGY (2015)
Drugging the p53 pathway: understanding the route to clinical efficacy
Khoo Kian Hoe et al.
NATURE REVIEWS DRUG DISCOVERY (2014)
Phase I Study of the Antiangiogenic Antibody Bevacizumab and the mTOR/Hypoxia-Inducible Factor Inhibitor Temsirolimus Combined with Liposomal Doxorubicin: Tolerance and Biological Activity
John Moroney et al.
CLINICAL CANCER RESEARCH (2012)
Responses to Liposomal Doxorubicin, Bevacizumab, and Temsirolimus in Metaplastic Carcinoma of the Breast: Biologic Rationale and Implications for Stem-Cell Research in Breast Cancer
Stacy Moulder et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Phenotypic and molecular characterization of the claudin-low intrinsic subtype of breast cancer
Aleix Prat et al.
BREAST CANCER RESEARCH (2010)
Metaplastic breast carcinomas are basal-like breast cancers: a genomic profiling analysis
Britta Weigelt et al.
BREAST CANCER RESEARCH AND TREATMENT (2009)
Characteristics and treatment of metaplastic breast cancer: Analysis of 892 cases from the National Cancer Data Base
Christopher M. Pezzi et al.
ANNALS OF SURGICAL ONCOLOGY (2007)
分享论文
